Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gas Exchange Derangement Physiopathology and Response to Different Levels of Positive End-expiratory Pressure in Critically Ill Patients With COVID-19

NCT05132933 is registered in ClinicalTrials.gov with Policlinico Hospital as lead sponsor.

NCT NCT05132933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05132933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gas Exchange Derangement Physiopathology and Response to Different Levels of Positive End-expiratory Pressure in Critically Ill Patients With COVID-19
Lead sponsor
Policlinico Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2021
Completion date
December 30, 2022
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory failure